 |
|
Say it ain’t so. Private Equity and Big Pharma batting their eyelashes at one another? One thing’s for sure, going private would certainly alter communications practices at a major drug company.
The Cycle
For both journalists and communicators, the news cycle never ends. At The Cycle, PRWeek’s editorial team offers commentary and viewpoints on how the latest marketing, business, political, and cultural news impact the PR industry.
Nielsen: Almost all US consumers responded to DTV transition
Fawcett’s death raises awareness about cancer, HPV vaccine
Yahoo signals brand overhaul with new hire
RSSThis material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions